Le Lézard
Classified in: Health, Business
Subject: VEN

AIVITA Biomedical Raises $15M USD in Series B Financing


IRVINE, Calif., June 11, 2018 /PRNewswire/ -- AIVITA Biomedical, a global biotech specializing in innovative stem cell applications, announced today that it has raised $15 million in a private Series B financing round. The financing is provided by SFC Co. Ltd., a South Korean investor that is listed on the KOSDAQ Stock Exchange. The financing will support AIVITA's commercial and clinical-stage programs.

AiVita Biomedical

"This funding is a reflection of AIVITA's meteoric development since it was founded 18 months ago," said Dr. Hans Keirstead, CEO of AIVITA Biomedical. "It will allow us to expand our clinical cancer programs, broaden our consumer product offerings and bring in additional staff to manage our expansion."

AIVITA Biomedical has both clinical and commercial programs. AIVITA's lead therapeutic candidate is a novel patient-specific immunotherapy for the treatment of advanced cancers, currently being used to treat ovarian cancer.

AIVITA has also launched a consumer skincare line, ROOT OF SKINtm, as the world's first skin care product that mimics the environment of developing skin. Its proprietary actives complex, SourceCode Technologytm, is exclusively manufactured in AIVITA's clinical-grade research facilities and available only in ROOT OF SKINtm products. Importantly, 100% of proceeds from the sale of ROOT OF SKINtm products support the treatment of women with ovarian cancer.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline.

 

SOURCE AIVITA Biomedical


These press releases may also interest you

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
Media Advisory - Minister Saks in Winnipeg to highlight Budget 2024: Fairness for Every Generation investments to boost research funding in Canada
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation Expands Reach to Virginia and Louisiana
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated Revises Time of First Quarter Webcast Teleconference to 7:00 a.m. (ET) on Thursday, May 2, 2024
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...

at 17:48
Hundreds of Community Leaders Kick Off Multi-city Convening in Bakersfield With a Simple Message: Do Not Cut San Joaquin Valley Programs & Services
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

More news about Health...


News published on and distributed by: